Ozeroff Christopher David
S.V.P., General Counsel
Avg. Two Year Performance
No Purchase Track Record
70% Avg. Sale Return
30% Compound
Holdings: 50.97K shares
Last Three Months: 12-Feb-24 -- 11-May-24
Sentiment
Company Sentiment
Biotechnology
Drugs
Two Year Chart
12-May-22 -- 11-May-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions